SlideShare a Scribd company logo
PHARMACOKINETICS
Yousaf khan
Renal dialysis lecturer
IPMS KMU
PASSAGE OF DRUG ACROSS CELL MEMBRANE
 Ability of drug to cross cell membrane
 Molecular size and shape
 Solubility at the site of absorption, degree of ionization and
lipid solubility.
Passive diffusion:
 Concentration gradient
 Depend upon lipid solubility and ionization
 Unionized drugs are more lipid soluble.
Filtration:
 Water soluble drugs
 Through porous membrane
 Hydrostatic pressure or osmotic pressure
2. FACILITATED DIFFUSION
 Specialized transmembrane carrier proteins
 These carrier proteins undergo conformational changes
 Allowing the passage of drugs or endogenous.
 It does not require energy, can be saturated, and may be
inhibited by compounds that compete for the carrier.
3. Active transport:
 involves specific carrier proteins
 Energy-dependent active transport is driven by the hydrolysis
of adenosine triphosphate.
 It is capable of moving drugs against a concentration gradient.
 The process is saturable, selective and may be compete
inhibited by other cotransported substances.
4. ENDOCYTOSIS AND EXOCYTOSIS
 This type of absorption is used to transport drugs of
exceptionally large size across the cell membrane.
 Endocytosis involves engulfment of a drug by the cell
membrane and transport into the cell by pinching off the
drugfilled vesicle.
 Exocytosis is the reverse of endocytosis..
ABSORPTION
Absorption is the transfer of a drug from its site of administration
to the blood stream.
Factors affecting drug absorption
1.Solubility:
 Higher lipid soluble – greater absorption rate
 Aqueous solution rapidly absorbed than those given in oily
solution, suspension or solid form.
2.Degree of ionization:
 Greater ionization – less absorption
 Lipid soluble are in unionized form – readily absorbed
 Water soluble drugs are in ionized form – can be absorbed –
very small molecular size
3.Effect of PH on drug absorption
 Most of drug are either weak acid or weak bases
 Acidic drug (HA) release proton causing a charged anion to
form
 Weak bases (BH+) can also release H+ ion. Protonated form
of basic drug is usually charged.
4. Pharmaceutical preparation:
 Solution are better absorbed than suspension
 Smaller the particle size of powders the more efficient their
absorption.
5. Route of administration:
 Parenteral routs is rapid than oral route
 Intramuscular route is rapid than from subcutaneous route
6. Surface area:
 Greater surface, larger will be the amount of drug absorbed
7. Concentration of drug:
 Greater concentration of the drug, greater will be the
concentration gradient
8. Local blood flow:
 Rate of absorption is directly proportional to the local blood
circulation
FACTORS MODIFYING ABSORPTION FROM GUT
1.Motility of the Gut:
 Helps in dissolution of tablets, increase the motility also increase rate
of absorption
2.Ph of the Gut:
 Weak acid are mostly unionized in acid medium- better absorbed
 Weak bases are unionized in alkaline medium- better absorbed
3.Disease condition:
 Effect rate of absorption
4.Presence of other substance:
Plasma half-life:
 Time it takes for the plasma concentration or the amount of drug in
the body to be reduced by 50%.
 The half-life of a drug depends on its clearance and volume of
distribution
 E.g For example, after intravenous administration, if maximum
concentration is 16 mg and the half life is 2 hours, after 2 hours 8 mg
will be left, and so on.
Factors affecting half-life
 Clearance decrease
 Volume of distribution
Steady state:
 Steady state concentration of drug occurs when the rate of drug
elimination is equal to the rate of drug administration.
 Steady state plasma concentration is directly proportional to rate of
infusion and inversely proportional to the total body clearance of the
drug.
Biological half life:
 The biological half-life or terminal half-life of a substance is the time it
takes for a substance to lose half of its pharmacologic, physiologic,
or radiologic activity,
BIOAVAILABILITY
 The fraction of unchanged drug reaching the systemic
circulation following administration by any route”
or
The percentage of administered drug that reaches the systemic
circulation in a chemically unchanged form”
 Thus by definition a drug that is administered by intravenous
route has 100% bioavailability
FACTORS AFFECTING BIOAVAILABILITY
1-Rout of administration:
2-First-pass hepatic metabolism:
 when a drug is absorbed across GIT, it enters the portal circulation
before entering the systemic circulation.
 If the drug is rapidly metabolized by the liver ,the amount of unchanged
drug that gains access to the systemic circulation is decreased
3-Absorption
4-Solubility of the drug:
 hydrophobic drug will absorb more so bioavailability will be more
5-Chemical instability:
 some drugs are unstable in pH of the gastric contents. Others are
destroyed in GIT by degradative enzymes
6-Particle size: smaller the particle size more absorption will be there.
DISTRIBUTION OF DRUGS
 Process by which drug reversibly leave blood stream and
enter interstitial and tissue.
 Such as plasma, extra cellular and intracellular fluid
depending upon its physicochemical properties.
 Substance of high molecular weight almost remain in water
plasma.
 Drug that can pass capillary wall but can not pass across the
cell membrane are localized mainly in extra cellular fluid. E.g
mannitol iv administration
 Cross cell membrane and do not have specific affinity for
specific tissue are distributed equally. E.g alcohol , urea
 Some drugs are concentrated especially in one or more tissue
of the body. E.g. iodide in thyroid gland
FACTORS THAT DETERMINE DRUG
DISTRIBUTION
1. Binding of drug to plasma protein and tissues
 Binding to plasma protein
 Bound to plasma protein to varying extent
 Binding of drug to albumin is reversible and may show
low or high capacity
 Albumin has the strongest affinity for anionic drugs and
hydrophobic drugs.
 Binding to tissue protein
 Drug accumulate in tissue leading to higher conc. In
tissue.
 As result of binding to lipid, protein or nucleic acid.
 Drug may also be actively transported into tissue.
 Tissue reservoirs may serve as major source of the drug
and prolong its action
BLOOD FLOW
 How rapidly drug molecules are delivered to a given tissue
 How effectively the conc. Gradient b/w blood and tissue is
maintained
 Drug equilibrate rapidly b/w the blood and organs with high
blood flow
 Capillary permeability
 Capillary structure and chemical nature of drug.
LIPOPHILICITY
 Lipophilic drug readily move across most biologic
membranes
 Dissolved and penetrate entire cell surface
 Hydrophilic drug do not readily penetrate cell
membrane and must pas through slit junction.
DRUG METABOLISM/BIOTRANSFORMATION
 The series of chemical alterations of drug that occurs
within the body
 How activity of drug terminated or altered.
 Some drug – excrete through kidney – no need of
metabolism.
 Lipophilic– promote- biological membrane- site of
action- reduce elimination
 Lipophilic drug convert into hydrophilic metabolites-
terminate biological activity and eliminate from the body.
 Site of drug metabolism:
liver, kidney, GIT, skin and lungs
ENZYME
 Cytochrome P-450 system
 Drug- elevate level of cytochrome p-450- increase rate of
metabolism– reduce action and duration of the drug.
 Drug– inhibit p-450 system and may potentate the action of
other drug that are metabolized by this system
PHASES OF METABOLISM
 First phase I and than Phase II
 Some drug pass through phase II and the phase I
 Some drug directly undergo through phase II.
 Phase I:
 Generally result in loss of pharmacological activity of drug
 Increase pharmacologically inactive become active after
metabolism
 Conversion of drug to a toxic compound
 Reaction include in type I reaction are
 Oxidative reaction
 Reduction reaction
 hydrolysis
.
PHASE II REACTION
o Conjugation of the parent compound with certain acid radical or
amino acids
o Metabolite from phase I metabolism is sufficient polar – excreted
by kidneys
o Many metabolite are too lipophilic to be excreted and they must
undergo conjugation reaction with endogenous substrate
o Phase II reaction result in inactivation of the parent drug but not
always
o Phase II reaction
o Glucuronidation
o Acetylation
o Glutathion conjugation
o Sulfate conjugation
o Methylation
o Water conjugation
FACTOR AFFECTING BIOTRANSFORMATION
Difference in drug distribution, metabolism and elimination due
to following factor
 Individual difference:
 Different people have different level of metabolism
 Genetic factors:
 Influence enzyme levels resulting in difference in drug
metabolism
 Diet and environmental factors:
 Certain vegetables and fruits induce or inhibit enzymes
affecting the drug metabolism
 Age and Sex;
 Drug have more effect and more toxicity – young and old
patient due decrease drug metabolism
 In newborn the enzyme in the liver are not developed.
 Male have more rapid drug metabolism than female.
 Drug – Drug interaction
 Interaction b/w drugs and endogenous compounds
 Diseases affecting drug metabolism
 Pharmacokinetic factors
CLEARANCE OF DRUG
 Clearance estimates the amount of drug cleared
from the body per unit of time.
 First order kinetics: if a constant fraction of drug is
eliminated per unit time, it is called first order kinetic
e.g. 5% or 10%
 Zero order kinetics: if a constant amount of drug is
eliminated per unit time it is called first order
kinetics, e.g. 5mg or 10 mg
DRUG CLEARANCE THROUGH METABOLISM
 Major route of elimination hepatic metabolism, biliary
elimination and urinary elimination,
 Elimination processes decrease plasma concentration.
 Constant fraction of drug present is eliminated in given unit of
time
A. Kinetics of metabolism:
 First order kinetics: if a constant fraction of drug is eliminated
per unit time, it is called first order kinetic e.g. 5% or 10%
 Zero order kinetics: if a constant amount of drug is eliminated
per unit time it is called first order kinetics, e.g. 5mg or 10 mg
 B: Reaction of drug metabolism:
 Kidney can not eliminate lipophilic drug
 First metabolized lipid soluble into more polar in the
liver through phase I and phase II.
DRUG CLEARANCE BY THE KIDNEY
 Polar to be eliminated
 Eliminate through kidney
 Glomerular filtration
 Proximal tubular secretion
 Distal tubular reabsorption
CLEARANCE BY OTHER ROUTE
 Intestine, bile lungs and breast milk
 Orally not absorbed directly eliminate through
intestine or into bile eliminate in the faces.
 Lung – anesthetic gases
 Excretion of most drugs into sweat, saliva, tears,
hair and skin.
Pharmacokinitic

More Related Content

What's hot

Solubility of drugs
Solubility of drugsSolubility of drugs
Solubility of drugs
Mahewash Sana Pathan
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
Naser Tadvi
 
kinetics of protein binding.pptx
kinetics of protein binding.pptxkinetics of protein binding.pptx
kinetics of protein binding.pptx
GitanjaliMehetre1
 
Absorption of drugs 2
Absorption of drugs 2Absorption of drugs 2
Absorption of drugs 2Danish Kurien
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug binding
Snehal Patel
 
Size separation
Size separationSize separation
Size separation
Ashwini Shewale
 
Drug absorption
Drug absorptionDrug absorption
Drug absorption
Sagar Savale
 
Kinetics and drug stability
Kinetics and drug stabilityKinetics and drug stability
Kinetics and drug stability
Prof. Dr. Basavaraj Nanjwade
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugs
wonderingsoul114
 
Bcs classification by sneha gaurkar
Bcs classification by sneha gaurkarBcs classification by sneha gaurkar
Bcs classification by sneha gaurkar
Sneha Gaurkar
 
Drug Dissolution
Drug DissolutionDrug Dissolution
Drug Dissolution
Sidharth Mehta
 
Drug distribution and protein binding
Drug distribution and protein bindingDrug distribution and protein binding
Drug distribution and protein binding
Anjali9410
 
Diffusion principles in biological systems
Diffusion principles in biological systemsDiffusion principles in biological systems
Diffusion principles in biological systems
Mahewash Sana Pathan
 
Biopharmaceutical factors affecting metabolism
Biopharmaceutical factors affecting metabolismBiopharmaceutical factors affecting metabolism
Biopharmaceutical factors affecting metabolism
SR drug laboratories
 
Parenterals
ParenteralsParenterals
Parenterals
Teny Thomas
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
Rishi Ram Parajuli
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
Naresh Gorantla
 
Quality control & evaluation test of aerosal
Quality control & evaluation test of aerosalQuality control & evaluation test of aerosal
Quality control & evaluation test of aerosal
Pritom Sinha
 
Elimination
EliminationElimination
Elimination
Kailas Mali
 

What's hot (20)

Solubility of drugs
Solubility of drugsSolubility of drugs
Solubility of drugs
 
Drug distribution
Drug distributionDrug distribution
Drug distribution
 
kinetics of protein binding.pptx
kinetics of protein binding.pptxkinetics of protein binding.pptx
kinetics of protein binding.pptx
 
Absorption of drugs 2
Absorption of drugs 2Absorption of drugs 2
Absorption of drugs 2
 
Protein drug binding
Protein drug bindingProtein drug binding
Protein drug binding
 
Size separation
Size separationSize separation
Size separation
 
Drug absorption
Drug absorptionDrug absorption
Drug absorption
 
Kinetics and drug stability
Kinetics and drug stabilityKinetics and drug stability
Kinetics and drug stability
 
Factors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of DrugsFactors Affecting Protein-Binding of Drugs
Factors Affecting Protein-Binding of Drugs
 
Bcs classification by sneha gaurkar
Bcs classification by sneha gaurkarBcs classification by sneha gaurkar
Bcs classification by sneha gaurkar
 
Buffers in Pharmacy
Buffers in PharmacyBuffers in Pharmacy
Buffers in Pharmacy
 
Drug Dissolution
Drug DissolutionDrug Dissolution
Drug Dissolution
 
Drug distribution and protein binding
Drug distribution and protein bindingDrug distribution and protein binding
Drug distribution and protein binding
 
Diffusion principles in biological systems
Diffusion principles in biological systemsDiffusion principles in biological systems
Diffusion principles in biological systems
 
Biopharmaceutical factors affecting metabolism
Biopharmaceutical factors affecting metabolismBiopharmaceutical factors affecting metabolism
Biopharmaceutical factors affecting metabolism
 
Parenterals
ParenteralsParenterals
Parenterals
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Quality control & evaluation test of aerosal
Quality control & evaluation test of aerosalQuality control & evaluation test of aerosal
Quality control & evaluation test of aerosal
 
Elimination
EliminationElimination
Elimination
 

Similar to Pharmacokinitic

Introduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principlesIntroduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principles
pooranachithra flowry
 
Drug Pharmacokinetics
Drug Pharmacokinetics Drug Pharmacokinetics
Drug Pharmacokinetics
A M O L D E O R E
 
chap no 1 INTRODUCTION TO PHARMACOLOGY 2.pptx
chap no 1 INTRODUCTION TO PHARMACOLOGY 2.pptxchap no 1 INTRODUCTION TO PHARMACOLOGY 2.pptx
chap no 1 INTRODUCTION TO PHARMACOLOGY 2.pptx
MahnoorFatima92
 
Basics of Pharmacology general pharmacology.....pptx
Basics of Pharmacology general pharmacology.....pptxBasics of Pharmacology general pharmacology.....pptx
Basics of Pharmacology general pharmacology.....pptx
MosaHasen
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsUniversity of Miami
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsUniversity of Miami
 
General Pharmacology-ADME
General Pharmacology-ADMEGeneral Pharmacology-ADME
General Pharmacology-ADME
Nisha Mhaske
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
vedanshu malviya
 
General Pharmacology part 02.pptx
General Pharmacology part 02.pptxGeneral Pharmacology part 02.pptx
General Pharmacology part 02.pptx
MAYUR HARAL
 
1 general pharmacology
1 general pharmacology1 general pharmacology
1 general pharmacology
Pranay Uplenchwar
 
Pharmacokinetic_absorption_and_distribut.pptx
Pharmacokinetic_absorption_and_distribut.pptxPharmacokinetic_absorption_and_distribut.pptx
Pharmacokinetic_absorption_and_distribut.pptx
Sumant Saini
 
Pharmacokinetics (1).ppt
Pharmacokinetics (1).pptPharmacokinetics (1).ppt
Pharmacokinetics (1).ppt
ssuser497f37
 
Pharmacokinetics dynamics and genetics
Pharmacokinetics dynamics and geneticsPharmacokinetics dynamics and genetics
Pharmacokinetics dynamics and genetics
krishna prasad dahal
 
Pharmacokinetics.pptx
Pharmacokinetics.pptxPharmacokinetics.pptx
Pharmacokinetics.pptx
Dr.Arka Mondal
 
General Pharmacology for BPT Students
General Pharmacology for BPT StudentsGeneral Pharmacology for BPT Students
General Pharmacology for BPT Students
Kalaivanisathishr
 
Basic Princioles of Pharmacokinetics 05 02 2023 BAA.pptx
Basic Princioles of Pharmacokinetics 05 02 2023   BAA.pptxBasic Princioles of Pharmacokinetics 05 02 2023   BAA.pptx
Basic Princioles of Pharmacokinetics 05 02 2023 BAA.pptx
maamedokuah233
 
Pharmacokinetics adme
Pharmacokinetics admePharmacokinetics adme
Pharmacokinetics adme
Deepa Urolagin
 
PHARMACOKINETICS.pptx
PHARMACOKINETICS.pptxPHARMACOKINETICS.pptx
PHARMACOKINETICS.pptx
JanhaviBurade
 
Pharmacokinetics2
Pharmacokinetics2Pharmacokinetics2
Pharmacokinetics2
SameerGanjave
 
Pharmacokinetics and drug disposition
Pharmacokinetics and drug dispositionPharmacokinetics and drug disposition
Pharmacokinetics and drug disposition
Sachin Kumar
 

Similar to Pharmacokinitic (20)

Introduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principlesIntroduction to pharmacokinetics and pharmacodynamics principles
Introduction to pharmacokinetics and pharmacodynamics principles
 
Drug Pharmacokinetics
Drug Pharmacokinetics Drug Pharmacokinetics
Drug Pharmacokinetics
 
chap no 1 INTRODUCTION TO PHARMACOLOGY 2.pptx
chap no 1 INTRODUCTION TO PHARMACOLOGY 2.pptxchap no 1 INTRODUCTION TO PHARMACOLOGY 2.pptx
chap no 1 INTRODUCTION TO PHARMACOLOGY 2.pptx
 
Basics of Pharmacology general pharmacology.....pptx
Basics of Pharmacology general pharmacology.....pptxBasics of Pharmacology general pharmacology.....pptx
Basics of Pharmacology general pharmacology.....pptx
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokinetics
 
Advanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokineticsAdvanced practice preparation pharmacokinetics
Advanced practice preparation pharmacokinetics
 
General Pharmacology-ADME
General Pharmacology-ADMEGeneral Pharmacology-ADME
General Pharmacology-ADME
 
Pharmacokinetics
PharmacokineticsPharmacokinetics
Pharmacokinetics
 
General Pharmacology part 02.pptx
General Pharmacology part 02.pptxGeneral Pharmacology part 02.pptx
General Pharmacology part 02.pptx
 
1 general pharmacology
1 general pharmacology1 general pharmacology
1 general pharmacology
 
Pharmacokinetic_absorption_and_distribut.pptx
Pharmacokinetic_absorption_and_distribut.pptxPharmacokinetic_absorption_and_distribut.pptx
Pharmacokinetic_absorption_and_distribut.pptx
 
Pharmacokinetics (1).ppt
Pharmacokinetics (1).pptPharmacokinetics (1).ppt
Pharmacokinetics (1).ppt
 
Pharmacokinetics dynamics and genetics
Pharmacokinetics dynamics and geneticsPharmacokinetics dynamics and genetics
Pharmacokinetics dynamics and genetics
 
Pharmacokinetics.pptx
Pharmacokinetics.pptxPharmacokinetics.pptx
Pharmacokinetics.pptx
 
General Pharmacology for BPT Students
General Pharmacology for BPT StudentsGeneral Pharmacology for BPT Students
General Pharmacology for BPT Students
 
Basic Princioles of Pharmacokinetics 05 02 2023 BAA.pptx
Basic Princioles of Pharmacokinetics 05 02 2023   BAA.pptxBasic Princioles of Pharmacokinetics 05 02 2023   BAA.pptx
Basic Princioles of Pharmacokinetics 05 02 2023 BAA.pptx
 
Pharmacokinetics adme
Pharmacokinetics admePharmacokinetics adme
Pharmacokinetics adme
 
PHARMACOKINETICS.pptx
PHARMACOKINETICS.pptxPHARMACOKINETICS.pptx
PHARMACOKINETICS.pptx
 
Pharmacokinetics2
Pharmacokinetics2Pharmacokinetics2
Pharmacokinetics2
 
Pharmacokinetics and drug disposition
Pharmacokinetics and drug dispositionPharmacokinetics and drug disposition
Pharmacokinetics and drug disposition
 

More from IPMS- KMU KPK PAKISTAN

Peritonitis
PeritonitisPeritonitis
Metabolic complication of peritoneal dialysis
Metabolic complication of peritoneal dialysisMetabolic complication of peritoneal dialysis
Metabolic complication of peritoneal dialysis
IPMS- KMU KPK PAKISTAN
 
Exit site infection in peritoneal dialysis patient
Exit site infection in peritoneal dialysis patientExit site infection in peritoneal dialysis patient
Exit site infection in peritoneal dialysis patient
IPMS- KMU KPK PAKISTAN
 
Complication of peritoneal dialysis
Complication of peritoneal dialysisComplication of peritoneal dialysis
Complication of peritoneal dialysis
IPMS- KMU KPK PAKISTAN
 
Acute peritoneal dialysis prescription
Acute peritoneal dialysis prescriptionAcute peritoneal dialysis prescription
Acute peritoneal dialysis prescription
IPMS- KMU KPK PAKISTAN
 
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysisAdequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
IPMS- KMU KPK PAKISTAN
 
Peritoneal dialysis catheter
Peritoneal dialysis catheterPeritoneal dialysis catheter
Peritoneal dialysis catheter
IPMS- KMU KPK PAKISTAN
 
Volume status and fluid overload in peritoneal dialysis
Volume status and fluid overload in peritoneal dialysisVolume status and fluid overload in peritoneal dialysis
Volume status and fluid overload in peritoneal dialysis
IPMS- KMU KPK PAKISTAN
 
Plasmapheresis
PlasmapheresisPlasmapheresis
Plasmapheresis
IPMS- KMU KPK PAKISTAN
 
Temporary vascular access for hemodialysis
Temporary vascular access for hemodialysisTemporary vascular access for hemodialysis
Temporary vascular access for hemodialysis
IPMS- KMU KPK PAKISTAN
 
Hemodialysis procedure
Hemodialysis procedureHemodialysis procedure
Hemodialysis procedure
IPMS- KMU KPK PAKISTAN
 
Permnent vascular access
Permnent vascular accessPermnent vascular access
Permnent vascular access
IPMS- KMU KPK PAKISTAN
 
Anticoagulation
AnticoagulationAnticoagulation
Anticoagulation
IPMS- KMU KPK PAKISTAN
 
Ultrafiltration
UltrafiltrationUltrafiltration
Ultrafiltration
IPMS- KMU KPK PAKISTAN
 
Product water and hemodialysis dialysis solution
Product water and hemodialysis dialysis solutionProduct water and hemodialysis dialysis solution
Product water and hemodialysis dialysis solution
IPMS- KMU KPK PAKISTAN
 
Dialysis machines key features
Dialysis machines key featuresDialysis machines key features
Dialysis machines key features
IPMS- KMU KPK PAKISTAN
 
Diarrhea and kidney failure
Diarrhea and kidney failureDiarrhea and kidney failure
Diarrhea and kidney failure
IPMS- KMU KPK PAKISTAN
 
Kidney failure in hypertension
Kidney failure in hypertensionKidney failure in hypertension
Kidney failure in hypertension
IPMS- KMU KPK PAKISTAN
 
Diabetic kidney disease
Diabetic kidney diseaseDiabetic kidney disease
Diabetic kidney disease
IPMS- KMU KPK PAKISTAN
 
Autonomic nervous system
Autonomic nervous systemAutonomic nervous system
Autonomic nervous system
IPMS- KMU KPK PAKISTAN
 

More from IPMS- KMU KPK PAKISTAN (20)

Peritonitis
PeritonitisPeritonitis
Peritonitis
 
Metabolic complication of peritoneal dialysis
Metabolic complication of peritoneal dialysisMetabolic complication of peritoneal dialysis
Metabolic complication of peritoneal dialysis
 
Exit site infection in peritoneal dialysis patient
Exit site infection in peritoneal dialysis patientExit site infection in peritoneal dialysis patient
Exit site infection in peritoneal dialysis patient
 
Complication of peritoneal dialysis
Complication of peritoneal dialysisComplication of peritoneal dialysis
Complication of peritoneal dialysis
 
Acute peritoneal dialysis prescription
Acute peritoneal dialysis prescriptionAcute peritoneal dialysis prescription
Acute peritoneal dialysis prescription
 
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysisAdequacy of peritoneal dialysis and chronic peritoneal dialysis
Adequacy of peritoneal dialysis and chronic peritoneal dialysis
 
Peritoneal dialysis catheter
Peritoneal dialysis catheterPeritoneal dialysis catheter
Peritoneal dialysis catheter
 
Volume status and fluid overload in peritoneal dialysis
Volume status and fluid overload in peritoneal dialysisVolume status and fluid overload in peritoneal dialysis
Volume status and fluid overload in peritoneal dialysis
 
Plasmapheresis
PlasmapheresisPlasmapheresis
Plasmapheresis
 
Temporary vascular access for hemodialysis
Temporary vascular access for hemodialysisTemporary vascular access for hemodialysis
Temporary vascular access for hemodialysis
 
Hemodialysis procedure
Hemodialysis procedureHemodialysis procedure
Hemodialysis procedure
 
Permnent vascular access
Permnent vascular accessPermnent vascular access
Permnent vascular access
 
Anticoagulation
AnticoagulationAnticoagulation
Anticoagulation
 
Ultrafiltration
UltrafiltrationUltrafiltration
Ultrafiltration
 
Product water and hemodialysis dialysis solution
Product water and hemodialysis dialysis solutionProduct water and hemodialysis dialysis solution
Product water and hemodialysis dialysis solution
 
Dialysis machines key features
Dialysis machines key featuresDialysis machines key features
Dialysis machines key features
 
Diarrhea and kidney failure
Diarrhea and kidney failureDiarrhea and kidney failure
Diarrhea and kidney failure
 
Kidney failure in hypertension
Kidney failure in hypertensionKidney failure in hypertension
Kidney failure in hypertension
 
Diabetic kidney disease
Diabetic kidney diseaseDiabetic kidney disease
Diabetic kidney disease
 
Autonomic nervous system
Autonomic nervous systemAutonomic nervous system
Autonomic nervous system
 

Recently uploaded

Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
beazzy04
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 

Recently uploaded (20)

Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345Sha'Carri Richardson Presentation 202345
Sha'Carri Richardson Presentation 202345
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 

Pharmacokinitic

  • 2. PASSAGE OF DRUG ACROSS CELL MEMBRANE  Ability of drug to cross cell membrane  Molecular size and shape  Solubility at the site of absorption, degree of ionization and lipid solubility. Passive diffusion:  Concentration gradient  Depend upon lipid solubility and ionization  Unionized drugs are more lipid soluble. Filtration:  Water soluble drugs  Through porous membrane  Hydrostatic pressure or osmotic pressure
  • 3. 2. FACILITATED DIFFUSION  Specialized transmembrane carrier proteins  These carrier proteins undergo conformational changes  Allowing the passage of drugs or endogenous.  It does not require energy, can be saturated, and may be inhibited by compounds that compete for the carrier. 3. Active transport:  involves specific carrier proteins  Energy-dependent active transport is driven by the hydrolysis of adenosine triphosphate.  It is capable of moving drugs against a concentration gradient.  The process is saturable, selective and may be compete inhibited by other cotransported substances.
  • 4. 4. ENDOCYTOSIS AND EXOCYTOSIS  This type of absorption is used to transport drugs of exceptionally large size across the cell membrane.  Endocytosis involves engulfment of a drug by the cell membrane and transport into the cell by pinching off the drugfilled vesicle.  Exocytosis is the reverse of endocytosis..
  • 5. ABSORPTION Absorption is the transfer of a drug from its site of administration to the blood stream. Factors affecting drug absorption 1.Solubility:  Higher lipid soluble – greater absorption rate  Aqueous solution rapidly absorbed than those given in oily solution, suspension or solid form. 2.Degree of ionization:  Greater ionization – less absorption  Lipid soluble are in unionized form – readily absorbed  Water soluble drugs are in ionized form – can be absorbed – very small molecular size
  • 6. 3.Effect of PH on drug absorption  Most of drug are either weak acid or weak bases  Acidic drug (HA) release proton causing a charged anion to form  Weak bases (BH+) can also release H+ ion. Protonated form of basic drug is usually charged. 4. Pharmaceutical preparation:  Solution are better absorbed than suspension  Smaller the particle size of powders the more efficient their absorption. 5. Route of administration:  Parenteral routs is rapid than oral route  Intramuscular route is rapid than from subcutaneous route
  • 7. 6. Surface area:  Greater surface, larger will be the amount of drug absorbed 7. Concentration of drug:  Greater concentration of the drug, greater will be the concentration gradient 8. Local blood flow:  Rate of absorption is directly proportional to the local blood circulation
  • 8. FACTORS MODIFYING ABSORPTION FROM GUT 1.Motility of the Gut:  Helps in dissolution of tablets, increase the motility also increase rate of absorption 2.Ph of the Gut:  Weak acid are mostly unionized in acid medium- better absorbed  Weak bases are unionized in alkaline medium- better absorbed 3.Disease condition:  Effect rate of absorption 4.Presence of other substance:
  • 9. Plasma half-life:  Time it takes for the plasma concentration or the amount of drug in the body to be reduced by 50%.  The half-life of a drug depends on its clearance and volume of distribution  E.g For example, after intravenous administration, if maximum concentration is 16 mg and the half life is 2 hours, after 2 hours 8 mg will be left, and so on. Factors affecting half-life  Clearance decrease  Volume of distribution
  • 10. Steady state:  Steady state concentration of drug occurs when the rate of drug elimination is equal to the rate of drug administration.  Steady state plasma concentration is directly proportional to rate of infusion and inversely proportional to the total body clearance of the drug. Biological half life:  The biological half-life or terminal half-life of a substance is the time it takes for a substance to lose half of its pharmacologic, physiologic, or radiologic activity,
  • 11. BIOAVAILABILITY  The fraction of unchanged drug reaching the systemic circulation following administration by any route” or The percentage of administered drug that reaches the systemic circulation in a chemically unchanged form”  Thus by definition a drug that is administered by intravenous route has 100% bioavailability
  • 12. FACTORS AFFECTING BIOAVAILABILITY 1-Rout of administration: 2-First-pass hepatic metabolism:  when a drug is absorbed across GIT, it enters the portal circulation before entering the systemic circulation.  If the drug is rapidly metabolized by the liver ,the amount of unchanged drug that gains access to the systemic circulation is decreased 3-Absorption 4-Solubility of the drug:  hydrophobic drug will absorb more so bioavailability will be more 5-Chemical instability:  some drugs are unstable in pH of the gastric contents. Others are destroyed in GIT by degradative enzymes 6-Particle size: smaller the particle size more absorption will be there.
  • 13. DISTRIBUTION OF DRUGS  Process by which drug reversibly leave blood stream and enter interstitial and tissue.  Such as plasma, extra cellular and intracellular fluid depending upon its physicochemical properties.  Substance of high molecular weight almost remain in water plasma.  Drug that can pass capillary wall but can not pass across the cell membrane are localized mainly in extra cellular fluid. E.g mannitol iv administration  Cross cell membrane and do not have specific affinity for specific tissue are distributed equally. E.g alcohol , urea  Some drugs are concentrated especially in one or more tissue of the body. E.g. iodide in thyroid gland
  • 14. FACTORS THAT DETERMINE DRUG DISTRIBUTION 1. Binding of drug to plasma protein and tissues  Binding to plasma protein  Bound to plasma protein to varying extent  Binding of drug to albumin is reversible and may show low or high capacity  Albumin has the strongest affinity for anionic drugs and hydrophobic drugs.  Binding to tissue protein  Drug accumulate in tissue leading to higher conc. In tissue.  As result of binding to lipid, protein or nucleic acid.  Drug may also be actively transported into tissue.  Tissue reservoirs may serve as major source of the drug and prolong its action
  • 15. BLOOD FLOW  How rapidly drug molecules are delivered to a given tissue  How effectively the conc. Gradient b/w blood and tissue is maintained  Drug equilibrate rapidly b/w the blood and organs with high blood flow  Capillary permeability  Capillary structure and chemical nature of drug.
  • 16. LIPOPHILICITY  Lipophilic drug readily move across most biologic membranes  Dissolved and penetrate entire cell surface  Hydrophilic drug do not readily penetrate cell membrane and must pas through slit junction.
  • 17. DRUG METABOLISM/BIOTRANSFORMATION  The series of chemical alterations of drug that occurs within the body  How activity of drug terminated or altered.  Some drug – excrete through kidney – no need of metabolism.  Lipophilic– promote- biological membrane- site of action- reduce elimination  Lipophilic drug convert into hydrophilic metabolites- terminate biological activity and eliminate from the body.  Site of drug metabolism: liver, kidney, GIT, skin and lungs
  • 18. ENZYME  Cytochrome P-450 system  Drug- elevate level of cytochrome p-450- increase rate of metabolism– reduce action and duration of the drug.  Drug– inhibit p-450 system and may potentate the action of other drug that are metabolized by this system
  • 19. PHASES OF METABOLISM  First phase I and than Phase II  Some drug pass through phase II and the phase I  Some drug directly undergo through phase II.  Phase I:  Generally result in loss of pharmacological activity of drug  Increase pharmacologically inactive become active after metabolism  Conversion of drug to a toxic compound  Reaction include in type I reaction are  Oxidative reaction  Reduction reaction  hydrolysis .
  • 20. PHASE II REACTION o Conjugation of the parent compound with certain acid radical or amino acids o Metabolite from phase I metabolism is sufficient polar – excreted by kidneys o Many metabolite are too lipophilic to be excreted and they must undergo conjugation reaction with endogenous substrate o Phase II reaction result in inactivation of the parent drug but not always o Phase II reaction o Glucuronidation o Acetylation o Glutathion conjugation o Sulfate conjugation o Methylation o Water conjugation
  • 21. FACTOR AFFECTING BIOTRANSFORMATION Difference in drug distribution, metabolism and elimination due to following factor  Individual difference:  Different people have different level of metabolism  Genetic factors:  Influence enzyme levels resulting in difference in drug metabolism  Diet and environmental factors:  Certain vegetables and fruits induce or inhibit enzymes affecting the drug metabolism  Age and Sex;  Drug have more effect and more toxicity – young and old patient due decrease drug metabolism  In newborn the enzyme in the liver are not developed.  Male have more rapid drug metabolism than female.
  • 22.  Drug – Drug interaction  Interaction b/w drugs and endogenous compounds  Diseases affecting drug metabolism  Pharmacokinetic factors
  • 23. CLEARANCE OF DRUG  Clearance estimates the amount of drug cleared from the body per unit of time.  First order kinetics: if a constant fraction of drug is eliminated per unit time, it is called first order kinetic e.g. 5% or 10%  Zero order kinetics: if a constant amount of drug is eliminated per unit time it is called first order kinetics, e.g. 5mg or 10 mg
  • 24. DRUG CLEARANCE THROUGH METABOLISM  Major route of elimination hepatic metabolism, biliary elimination and urinary elimination,  Elimination processes decrease plasma concentration.  Constant fraction of drug present is eliminated in given unit of time A. Kinetics of metabolism:  First order kinetics: if a constant fraction of drug is eliminated per unit time, it is called first order kinetic e.g. 5% or 10%  Zero order kinetics: if a constant amount of drug is eliminated per unit time it is called first order kinetics, e.g. 5mg or 10 mg
  • 25.  B: Reaction of drug metabolism:  Kidney can not eliminate lipophilic drug  First metabolized lipid soluble into more polar in the liver through phase I and phase II.
  • 26. DRUG CLEARANCE BY THE KIDNEY  Polar to be eliminated  Eliminate through kidney  Glomerular filtration  Proximal tubular secretion  Distal tubular reabsorption
  • 27. CLEARANCE BY OTHER ROUTE  Intestine, bile lungs and breast milk  Orally not absorbed directly eliminate through intestine or into bile eliminate in the faces.  Lung – anesthetic gases  Excretion of most drugs into sweat, saliva, tears, hair and skin.